Synbiotics for the Management of Cancer, 1st ed. 2023

This book illustrates the significance of probiotics and prebiotics for the management of various types of cancers. The up-to-date chapters provide recent information about the effect of anticancer treatment approaches on gut microbiota, the correlation between ROS and synbiotics for effective cancer treatment, and the influence of synbiotics on inflammation and immune microenvironment for cancer treatment. It also describes the regulatory issues about synbiotics in the management of cancer. This book is an essential resource for scientists working in the field of cancer, pharmaceutical & clinical sciences, and cancer clinicians. This book is also very useful for undergraduate and postgraduate students of Pharmacy and Biotechnology and medical researchers, mainly working in microbiology, immunology, and cancer biology.

Chapter 1_Introduction to Cancer.- Chapter 2_Effect of anticancer treatment approches on gut microbiota.- Chapter 3_Synbiotic: A promising approach for the treatment of cancer.- Chapter 4_Correlation between ROS and Synbiotics for effective treatment of cancer.- Chapter 5_Influence of synbiotics on inflammation and immune microenvironment for the treatment of cancer.- Chapter 6_Synbiotics in colorectal cancer.- Chapter 7_Synbiotics in cervical cancer.- Chapter 8_Synbiotics in prostate cancer.- Chapter 9_Synbiotics in gastric cancer.- Chapter 10_Synbiotics in lung cancer.- Chapter 11_Synbiotics in small cell pancretatic cancer.- Chapter 12_Synbiotics in breast cancer.- Chapter 13_Synbiotics in hepatocellular carcinoma.- Chapter 14_Synbiotics in ovarian cancer.- Chapter 15_Regulatory issues of synbiotics in cancer.

Dr. Neeraj Mishra is working as Professor in Amity Institute of Pharmacy, Gwalior since July 2019. Has done his M Pharm and Ph.D. in Pharmaceutics from Dr. H.S. Gour Central University, Sagar (M.P.), India. He is having around twenty years teaching and research experience. He is having around 100 publications of International and National repute in recent concept of novel drug delivery system, localized drug delivery, targeted and controlled drug delivery of nanocarriers/ microparticles for treatment of breast, colon cancer and neurodegenerative disorders. Dr. Mishra is having total citation 2750; h- index 25 and i- index 32. The total cumulative Impact Factor of his published papers is around 300 (as per SCOPUS). He is also written 5 Books and 9 book chapter in national and international publisher. He has also published 3 International and 3 National patents. Dr. Mishra has also received “Distinguished Professor Award” 2019, from DST- SPAICS in the workshop held at Smriti College of Pharmaceutical Education and Research, M.P., India. Recently, Dr. Mishra has received “Distinguished Professor Award” 2021 from IPA, MP State Branch, Indore. He also served as Guest Editor of Thematic issue entitled “Nanoparticulate Carriers for the treatment of Infectious Diseases and Cancer”, Current Molecular Pharmacology, Volume 14, 2021, Issue number 3, Bentham Sciences, USA.

Dr. Shvetank Bhatt is currently working as an Associate Professor in School of Pharmacy, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India. He has done M.Pharm in Pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka and Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. He has total 16 years of industrial and academic research experience. His are of specialization is CNS disorders, pain, inflammation and immunooncol

Explores the role of the synbiotics in prevention and treatment of different cancers

Discusses correlation between ROS and synbiotics for effective treatment of cancer

Examines regulatory issues of synbiotics in the management of cancer